METABOLISM OF CLENBUTEROL IN RATS

Citation
D. Zalko et al., METABOLISM OF CLENBUTEROL IN RATS, Drug metabolism and disposition, 26(9), 1998, pp. 891-899
Citations number
22
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00909556
Volume
26
Issue
9
Year of publication
1998
Pages
891 - 899
Database
ISI
SICI code
0090-9556(1998)26:9<891:MOCIR>2.0.ZU;2-2
Abstract
The metabolic fate of [C-14]clenbuterol was studied in male and female Wistar rats. After a single oral dose of 200 mu g/kg [C-14]clenbutero l, in an 8-day study period, approximately 60% of the radioactivity wa s eliminated in urine; 20 and 30% of the radioactivity was excreted in feces by male and female rats, respectively. HPLC coupled to on-line radioactivity detection allowed the separation and quantitation of cle nbuterol metabolites, some of which were found to be poorly stable in urine. Most of the urinary and fecal metabolites of clenbuterol were i solated and identified using various MS techniques. Analytical methods were also developed to establish the metabolic profiles in feces and tissues, up to 72 hr after clenbuterol administration. Clenbuterol was mainly metabolized by N-dealkylation (secondary amine), as well as N- oxidation and sulfate conjugation (primary amine). Gender-related diff erences in the rates of clenbuterol N-dealkylation were observed. 4-N- Hydroxylamine was the major metabolite detected in urine, whereas more than one half of the radioactivity in feces was associated with clenb uterol sulfamate.